Trademark Overview
On Tuesday, February 3, 2026, a trademark application was filed for DEFINIUM THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the DEFINIUM THERAPEUTICS trademark a serial number of 99632100. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, June 2, 2026. This trademark is owned by Definium Therapeutics US, Inc.. The DEFINIUM THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceuticals; pharmaceutical preparations; pharmaceuticals for the treatment of mental health conditions; pharmaceutical preparations for the treatment of mental health conditions; pharmaceutical preparations, namely, psychotropic, psychoactive, and psychedelic medicinal preparations for the treatment of mental health conditions; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, anxiety, depression, post-traumatic stress disorder, and mood disorders; pharmaceutical preparations for the treatment of substance-use and addictive disorders
Drug discovery services; pharmaceutical drug development services; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the fields of pharmaceuticals; research and development in the pharmaceutical and biotechnology fields; pharmaceutical research and development in the fields of psychiatry, neurology, and addiction medicine; medical and scientific research, namely, conducting clinical trials for others in the field of psychedelic-based therapeutics
